Headlands Technologies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,268
Closed -$1.65M 1169
2024
Q2
$1.65M Buy
5,268
+4,218
+402% +$1.24M 0.17% 116
2024
Q1
$299K Sell
1,050
-379
-27% -$111K 0.07% 284
2023
Q4
$412K Sell
1,429
-1,250
-47% -$341K 0.12% 157
2023
Q3
$720K Sell
2,679
-3,390
-56% -$846K 0.35% 69
2023
Q2
$1.35M Buy
+6,069
New +$1.41M 0.43% 53

Other funds holding AMGN

Headlands Technologies's AMGN Position: Q3 2024 in Review

Headlands Technologies sold out of Amgen (AMGN) in Q3 2024, closing a stake of 5,268 shares — an estimated $1.65M sold.

Headlands Technologies first reported a position in AMGN in Q2 2023 and held it in 5 quarters. The position peaked at $1.65M in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Headlands Technologies reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Headlands Technologies sold 5,268 Amgen shares in Q3 2024, an estimated $1.65M.
  • Headlands Technologies first reported a position in Amgen in Q2 2023 and held it in 5 quarters.
  • Headlands Technologies's Amgen position peaked at $1.65M in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Headlands Technologies's 13F filing for Q3 2024, filed 12 Nov 2024.